AGB Scientific

AGB Scientific specializes in a wide array of laboratory products and services, facilitating scientific research, quality control, and compliance in industrial applications. AGB Scientific operates within the scientific research sector, focusing on providing essential laboratory supplies and equipment. In April 2005, the company was acquired by VWR International, a subsidiary of Clayton Dubilier & Rice. The firm is headquartered in Dublin, Ireland, and has been identified as having one total deal in its historical data.

The company specializes in providing a comprehensive range of laboratory products and services, primarily aimed at supporting the needs of scientific research, quality control, and industrial applications. Their core offerings include laboratory supplies, chemicals, equipment, and safety products, which are designed to enhance operational efficiency and ensure compliance with regulatory standards. The end-use cases addressed by these products span various sectors including biotechnology, pharmaceuticals, environmental testing, and academic research institutions. The company serves a diverse client base comprising laboratories, universities, and research facilities across multiple geographical markets, including North America, Europe, and Asia-Pacific.

By delivering innovative solutions, the company caters to the evolving demands of its customers, ensuring they have access to high-quality products tailored to their specific applications. In 2023, AGB Scientific reported a revenue of USD 132. 64 mn, with an EBITDA of USD 10. 24 mn.

The company generates revenue through a structured transaction model that encompasses both B2B and direct-to-consumer sales. These transactions are facilitated via a combination of wholesale partnerships and direct contracts with various institutions and organizations. Clients engage with the firm on a recurring basis, often through subscription services for consumable products or through one-time purchases of specialized laboratory equipment. Pricing structures are established for flagship products, which are competitively positioned to meet market demands while reflecting the quality and reliability customers expect.

The revenue streams are bolstered by ongoing relationships with clients, who benefit from tailored solutions designed to address their unique operational challenges, thereby driving sustained business growth. AGB Scientific's future growth strategy includes the development and launch of new products tailored to meet the evolving needs of the laboratory market. The company aims to expand its presence in the Asia-Pacific region by the end of 2024, leveraging its existing client relationships and exploring new partnerships. The April 2005 acquisition by VWR International continues to provide operational synergies that support these initiatives.